ES2108240T3 - Derivados de tiosemicarbazona de 2-formilpiridina, su preparacion y su uso como agentes antitumor. - Google Patents

Derivados de tiosemicarbazona de 2-formilpiridina, su preparacion y su uso como agentes antitumor.

Info

Publication number
ES2108240T3
ES2108240T3 ES93401234T ES93401234T ES2108240T3 ES 2108240 T3 ES2108240 T3 ES 2108240T3 ES 93401234 T ES93401234 T ES 93401234T ES 93401234 T ES93401234 T ES 93401234T ES 2108240 T3 ES2108240 T3 ES 2108240T3
Authority
ES
Spain
Prior art keywords
hydrogen
thosemicarbazone
formilpiridina
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93401234T
Other languages
English (en)
Inventor
Alan C Sartorelli
Tai-Shun Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Application granted granted Critical
Publication of ES2108240T3 publication Critical patent/ES2108240T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE UN COMPUESTO ACTIVO DE LA FORMULA: EN DONDE: BIEN (A) R1 ES NHR4, NR4R5 U OH Y R3 ES HIDROGENO O (B) R3 ES NHR4, NR4R5 U OH Y R1 ES HIDROGENO; R2 ES HIDROGENO O ALKILO INFERIOR C1-4; R4 ES HIDROGENO, HIDROXILO O ALKILO INFERIOR C1-4; Y R5 ES ALKILO INFERIOR C1-4; SIEMPRE Y CUANDO SI R1 ES OH, R2 SEA METILO Y SIEMPRE Y CUANDO SI R3 ES N(CH3)2 U OH, R1 Y R2 NO SEAN LOS DOS HIDROGENO O UNA SAL FARMACEUTICAMENTE ACEPTABLE O HIDRATO DEL MISMO PARA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE UN TUMOR EN UN MAMIFERO, ASI COMO A NUEVOS COMPUESTOS DE LA FORMULA (I) EXCEPTO AL COMPUESTO EN DONDE R1 ES OH, R2 ES METILO Y R3 ES HIDROGENO Y A LA COMPOSICION FARMACEUTICA CORRESPONDIENTE.
ES93401234T 1992-05-13 1993-05-13 Derivados de tiosemicarbazona de 2-formilpiridina, su preparacion y su uso como agentes antitumor. Expired - Lifetime ES2108240T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/882,154 US5281715A (en) 1992-05-13 1992-05-13 2-formylpyridine thiosemicarbazone compounds

Publications (1)

Publication Number Publication Date
ES2108240T3 true ES2108240T3 (es) 1997-12-16

Family

ID=25379994

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93401234T Expired - Lifetime ES2108240T3 (es) 1992-05-13 1993-05-13 Derivados de tiosemicarbazona de 2-formilpiridina, su preparacion y su uso como agentes antitumor.

Country Status (9)

Country Link
US (2) US5281715A (es)
EP (1) EP0570294B1 (es)
JP (1) JP3192027B2 (es)
AT (1) ATE156119T1 (es)
CA (1) CA2095881C (es)
DE (1) DE69312567T2 (es)
DK (1) DK0570294T3 (es)
ES (1) ES2108240T3 (es)
GR (1) GR3025207T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2065299C1 (ru) * 1994-07-15 1996-08-20 Акционерное общество закрытого типа "Олвик" Ноотропное и транквилизирующее средство
US5767134A (en) * 1997-05-15 1998-06-16 Vion Pharmaceuticals, Inc. Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
US6040338A (en) * 1997-11-03 2000-03-21 Yale University N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents
US7456179B2 (en) * 2003-05-01 2008-11-25 Panacea Pharmaceuticals, Inc. Methods of treating ischemic related conditions
WO2004109290A2 (en) * 2003-05-30 2004-12-16 Rosetta Inpharmatics Llc Methods for identifying modulators of kinesin activity
US20060194810A1 (en) * 2004-04-30 2006-08-31 Bijan Almassian Methods of treating ischemic related conditions
AU2006292482A1 (en) * 2005-09-16 2007-03-29 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
MD4126C1 (ro) * 2010-11-15 2012-04-30 Государственный Университет Молд0 N,N'-[4,4'-(perfluoro-1,4-fenilendioxi)-bis(4,1-fenilen)]-bis[2-(piridin-2-ilmetilen)hidrazincarbotioamidă] şi utilizarea ei în calitate de inhibitor al proliferării celulelor LNCaP ale cancerului prostatei
US20140271812A1 (en) 2013-03-14 2014-09-18 Panacea Pharmaceuticals Treatment for chemotherapy-induced cognitive impairment
US20140287021A1 (en) 2013-03-21 2014-09-25 Panacea Pharmaceuticals Treatment of chemotherapy-induced peripheral neuropathy
MD4349C1 (ro) * 2014-06-23 2015-12-31 Государственный Университет Молд0 Compusul N-(3-metoxifenil)-2-(piridin-2-ilmetilen)-hidrazincarbotioamidă - inhibitor al proliferării celulelor MeW-164 ale melanomului uman
MD4407C1 (ro) * 2015-04-29 2016-10-31 Государственный Университет Молд0 Inhibitor al celulelor HL-60 ale leucemiei umane mieloide în baza hidratului clorurii de bis[N-(prop-2-en-1-il)-2-(piridin-2-ilmetiliden)-hidrazincarbotioamid]-nichel(II)
MD4393C1 (ro) * 2015-09-04 2016-08-31 Государственный Университет Молд0 Inhibitor al celulelor HL-60 ale leucemiei umane mieloide în baza nitrato-[N′-(1-piridin-2-ilmetiliden)morfolin-4-carbotiohidrazido(1-)]cupru
MD4434C1 (ro) * 2015-10-09 2017-04-30 Государственный Университет Молд0 Utilizarea N'-[1-(2-piridil)etiliden]morfolin-4-carbotiohidrazidei în calitate de inhibitor al proliferării celulelor HL-60 ale leucemiei mieloide umane
MD4520C1 (ro) * 2016-12-16 2018-05-31 Государственный Университет Молд0 N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamida în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar
CN109265453A (zh) * 2018-10-23 2019-01-25 华侨大学 一种用作caspase-3激活剂的缩氨基脲类衍生物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations

Also Published As

Publication number Publication date
GR3025207T3 (en) 1998-02-27
DE69312567D1 (de) 1997-09-04
EP0570294A1 (en) 1993-11-18
ATE156119T1 (de) 1997-08-15
DE69312567T2 (de) 1998-03-19
JPH06128230A (ja) 1994-05-10
JP3192027B2 (ja) 2001-07-23
US5721259A (en) 1998-02-24
US5281715A (en) 1994-01-25
EP0570294B1 (en) 1997-07-30
CA2095881C (en) 2002-01-22
DK0570294T3 (da) 1998-02-02
CA2095881A1 (en) 1993-11-14

Similar Documents

Publication Publication Date Title
ES2108240T3 (es) Derivados de tiosemicarbazona de 2-formilpiridina, su preparacion y su uso como agentes antitumor.
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
DE69328192T2 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
ES513108A0 (es) "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina".
ES2114931T3 (es) Nuevos esteres esteroidales.
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
SE8801513L (sv) Farmaceutisk komposition
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
KR900014385A (ko) 제약학적 치료
ES8608522A1 (es) Un procedimiento para preparar pirido (3,4-r) psoralenos o pirido-(3',4';4,5) furo (3,2-g) curaminas.
ES2038621T3 (es) Utilizacion de gangliosidos exogenos para la preparacion de un medicamento a utilizar en enfermedades tumorales como factor de proteccion contra la toxicidad por medicamentos antitumorales.
AP9801235A0 (en) Erythromycin derivatives.
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
ES2039373T3 (es) Esteroides utiles como agentes anticancerigenos y antiobesidad, una composicion terapeutica que los contiene y su uso para la preparacion de una composicion terapeutica.
AR029259A1 (es) Compuestos 1,1'(1,2 etendiilo) bis (benceno) sustituidos, un proceso para su preparacion composiciones farmaceuticas y el uso de dichos compuestos para preparar agentes intensificadores de la absorcion de glucosa
MX9203068A (es) Compuestos activirales oralmente activos.
AR002716A1 (es) Uso farmacologico de ciertos derivados de cistina para la preparacion de un medicamento
ES2145740T3 (es) Composiciones de factor de crecimiento, preparacion y uso.
ES477257A1 (es) Un procedimiento para preprarar derivados de isoquinoleina.
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
JPS5527133A (en) Drug comprising organosilicon compound as main constituent
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MX169275B (es) Proceso para la preparacion de derivados de 6-deoxi guanidina
JPS5639018A (en) Remedy for cancer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 570294

Country of ref document: ES